Open-architecture Bindi® technology, developed by Avanti NanoSciences, is ideally suited to a wide range of applications throughout the life Science research domains, biopharmaceutical product development, molecular diagnostics, clinical trials end point monitoring of biomarkers, microbial detection and monitoring, bioagent detection and monitoring as well as basic research. Highly sensitive and accurate, yet designed for high throughput and increased assay speed, Bindi® technology can help clinicians and researchers alike save time and costs while boosting productivity.

Learn more about our rapidly expanding list of innovative Life Science applications that we are developing or intend to develop with our partners at Universities, research institutes and other commercial partners.

EndoSense-Endotoxin Detection

Endostrip- Endotoxin Removal

 

OncoAlert-Cancer detection biomarkers

ClinAlert- Biomarkers for clinical end point monitoring

Infectious diseases

Cancer

Metabolic Disorders

Healthcare-Drug resistant Staph

Streptococci detection

Environmental and food pathogen monitoring

 

Bioagent detection and Monitoring

Bioagent Decontamination

Clinical protocol development

Biomarker Validation

Assay Development